Skip to content

A Prospective Multi-center Study on Total Hip Arthroplasty With E1

A Prospective Multi-center Randomized Study on Total Hip Replacement With E1

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01883492
Enrollment
153
Registered
2013-06-21
Start date
2013-03-11
Completion date
2019-03-15
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Keywords

Only Female, Age between 20 - 75 at the time of operation

Brief summary

The primary objectives of this clinical study include: * Evaluate E1 Wear including early bedding-in process, clinical outcomes on patients who received Total Hip Arthroplasty with E1 * Compare E1 wear used with CoCr and Biolox Delta heads

Detailed description

This study is designed as PROSPECTIVE, RANDOMIZED, MULTI-CENTER Study to compare two different materials (CoCr and Delta ceramic) articulating against E1 Highly Crosslinked polyethylene in Hip Replacement. Patient population is 160 (80 each). Follow-up period is 10 year postoperatively. E1 liners with thickness of 4.8mm at 45 degrees position (load bearing direction) will be used in all cases. Randomization will occur via random number generator by 4 blocks randomization.

Interventions

DEVICEFemoral Stem

JMDN classification/Class III device

JMDN classification: Class III device

DEVICEAcetabular Liner

JMDN classification: Class III device

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Osteoarthritis * Age between 20 - 75 at the time of operation * Patients with limited co-morbidity -ASA I-III * Patients must be able to understand instructions and be willing to return for follow up

Exclusion criteria

* In accordance with approved Absolute and Relative Contraindications for use in participating countries for E1 liner and Delta Ceramic and CoCr femoral head hip system System. Absolute contraindications include: infection, sepsis, and osteomyelitis. Relative contraindications include: 1. uncooperative patient or patient with neurologic disorders who are incapable of following directions, 2. osteoporosis, 3. metabolic disorders which may impair bone formation, 4. osteomalacia, 5. distant foci of infections which may spread to the implant site, 6. rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, and 7. vascular insufficiency, muscular atrophy, or neuromuscular disease. 8. pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Polyethylene Wear Between Immediate Postoperative and 2 Year Postoperative PeriodImmediate postoperative and 2 year postoperativelyVector wear, which is defined as movement (difference of femoral prosthetic head positions) between immediate postoperative and 2 years postoperative periods. There is no lower and upper limit, actual measured results. The outcome can be negative value.

Secondary

MeasureTime frameDescription
Harris Hip Score at 1 Year Follow-up Visit1 year postoperativeHarris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.
Harris Hip Score at 2 Year Follow-up Visit2 year postoperativeHarris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.
Harris Hip Score at 3 Year Follow-up Visit3 year postoperativeHarris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.
WOMAC Osteoarthritis Index at 6 Month Follow-up Visit6 month postoperativeThe Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
WOMAC Osteoarthritis Index at 1 Year Follow-up Visit1 year postoperativeThe Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
Harris Hip Score at 6 Month Follow-up Visit6 month postoperativeHarris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.
WOMAC Osteoarthritis Index at 3 Year Follow-up Visit3 year postoperativeThe Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
UCLA Activity Score at 6 Month Follow-up Visit6 month postoperativeUniversity of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.
UCLA Activity Score at 1 Year Follow-up Visit1 year postoperativeUniversity of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.
UCLA Activity Score at 2 Year Follow-up Visit2 year postoperativeUniversity of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.
UCLA Activity Score at 3 Year Follow-up Visit3 year postoperativeUniversity of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.
WOMAC Osteoarthritis Index at 2 Year Follow-up Visit2 year postoperativeThe Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

Countries

Japan

Participant flow

Participants by arm

ArmCount
BIOLOX Delta Head
Uncemented Femoral Stem is inserted into femoral medullary canal. Uncemented Acetabular Cup is inserted into acetabular cavity with or without fixation screw(s). Acetabular Liner, which is made of E1 highly crosslinked polyethylene, is fitted into Acetabular cup. Biolox delta head is inserted onto the taper of the Femoral stem, and is articulating against Acetabular Liner made of E1. Femoral Stem: JMDN classification/Class III device Acetabular Cup: JMDN classification: Class III device Acetabular Liner: JMDN classification: Class III device
62
CoCr Head
Uncemented Femoral Stem is inserted into femoral medullary canal. Uncemented Acetabular Cup is inserted into acetabular cavity with or without fixation screw(s). Acetabular Liner, which is made of E1 highly crosslinked polyethylene, is fitted into Acetabular cup. CoCr head is inserted onto the taper of the Femoral stem, and is articulating against Acetabular Liner made of E1. Femoral Stem: JMDN classification/Class III device Acetabular Cup: JMDN classification: Class III device Acetabular Liner: JMDN classification: Class III device
67
Total129

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studybone anatomy did not meet study criteria11
Overall Studyinappropriate implant used11
Overall StudyLost to Follow-up34
Overall StudyPoor X-ray quality74
Overall StudySurgery on contra-lateral hip01
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicCoCr HeadTotalBIOLOX Delta Head
Age, Continuous61.94 years
STANDARD_DEVIATION 7.26
61.92 years
STANDARD_DEVIATION 7.18
61.90 years
STANDARD_DEVIATION 7.16
Harris Hip Score52.63 score on scale
STANDARD_DEVIATION 11.67
53.83 score on scale
STANDARD_DEVIATION 11.68
55.11 score on scale
STANDARD_DEVIATION 11.65
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
67 Participants129 Participants62 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Japan
67 participants129 participants62 participants
Sex: Female, Male
Female
67 Participants129 Participants62 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
UCLA Activity Score3.28 score on scale
STANDARD_DEVIATION 1.1
3.12 score on scale
STANDARD_DEVIATION 1.04
2.95 score on scale
STANDARD_DEVIATION 0.95
WOMAC osteoarthritis index41.24 score on scale
STANDARD_DEVIATION 15.29
41.00 score on scale
STANDARD_DEVIATION 16.13
40.75 score on scale
STANDARD_DEVIATION 17.09

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 620 / 67
other
Total, other adverse events
2 / 621 / 67
serious
Total, serious adverse events
0 / 620 / 67

Outcome results

Primary

Polyethylene Wear Between Immediate Postoperative and 2 Year Postoperative Period

Vector wear, which is defined as movement (difference of femoral prosthetic head positions) between immediate postoperative and 2 years postoperative periods. There is no lower and upper limit, actual measured results. The outcome can be negative value.

Time frame: Immediate postoperative and 2 year postoperatively

Population: Participants, whose x-ray taken at 2 year follow-up visit being available.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadPolyethylene Wear Between Immediate Postoperative and 2 Year Postoperative Period0.42 millimeterStandard Deviation 1.08
CoCr HeadPolyethylene Wear Between Immediate Postoperative and 2 Year Postoperative Period0.15 millimeterStandard Deviation 0.7
Secondary

Harris Hip Score at 1 Year Follow-up Visit

Harris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.

Time frame: 1 year postoperative

Population: 1 patient in BIOLOX delta head group and 6 patients in CoCr head group missed collecting Harris Hip Score at 1 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadHarris Hip Score at 1 Year Follow-up Visit95.23 score on a scaleStandard Deviation 6.1
CoCr HeadHarris Hip Score at 1 Year Follow-up Visit94.52 score on a scaleStandard Deviation 6.76
Secondary

Harris Hip Score at 2 Year Follow-up Visit

Harris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.

Time frame: 2 year postoperative

Population: 3 patients in BIOLOX delta head group and 9 patients in CoCr head group missed collecting Harris Hip Score at 2 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadHarris Hip Score at 2 Year Follow-up Visit96.15 score on a scaleStandard Deviation 5.44
CoCr HeadHarris Hip Score at 2 Year Follow-up Visit96.28 score on a scaleStandard Deviation 5.69
Secondary

Harris Hip Score at 3 Year Follow-up Visit

Harris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.

Time frame: 3 year postoperative

Population: 12 patients in BIOLOX delta head group and 12 patients in CoCr head group missed collecting Harris Hip Score at 3 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadHarris Hip Score at 3 Year Follow-up Visit96.30 score on a scaleStandard Deviation 4.56
CoCr HeadHarris Hip Score at 3 Year Follow-up Visit96.82 score on a scaleStandard Deviation 6.03
Secondary

Harris Hip Score at 6 Month Follow-up Visit

Harris Hip Score is Physician rating score to evaluate hip disabilities. Score domains are pain, function, absence of deformity and range of hip motion. Minimum possible score is 0 and maximum possible score is 100. Higher score means better outcome.

Time frame: 6 month postoperative

Population: 1 patient in BIOLOX delta head group and 13 patients in CoCr head group missed collecting Harris Hip Score at 6 month visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadHarris Hip Score at 6 Month Follow-up Visit92.67 score on a scaleStandard Deviation 8.05
CoCr HeadHarris Hip Score at 6 Month Follow-up Visit92.61 score on a scaleStandard Deviation 7.92
Secondary

UCLA Activity Score at 1 Year Follow-up Visit

University of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.

Time frame: 1 year postoperative

Population: 2 patients in BIOLOX delta head group and 8 patients in CoCr head group missed colleting UCLA Activity score at 1 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadUCLA Activity Score at 1 Year Follow-up Visit5.45 score on a scaleStandard Deviation 1.52
CoCr HeadUCLA Activity Score at 1 Year Follow-up Visit5.03 score on a scaleStandard Deviation 1.27
Secondary

UCLA Activity Score at 2 Year Follow-up Visit

University of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.

Time frame: 2 year postoperative

Population: 3 patients in BIOLOX delta head group and 9 patients in CoCr head group missed colleting UCLA Activity score at 2 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadUCLA Activity Score at 2 Year Follow-up Visit5.53 score on a scaleStandard Deviation 1.38
CoCr HeadUCLA Activity Score at 2 Year Follow-up Visit5.31 score on a scaleStandard Deviation 1.3
Secondary

UCLA Activity Score at 3 Year Follow-up Visit

University of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.

Time frame: 3 year postoperative

Population: 12 patients in BIOLOX delta head group and 11 patients in CoCr head group missed colleting UCLA Activity score at 3 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadUCLA Activity Score at 3 Year Follow-up Visit5.42 score on a scaleStandard Deviation 1.49
CoCr HeadUCLA Activity Score at 3 Year Follow-up Visit5.43 score on a scaleStandard Deviation 1.36
Secondary

UCLA Activity Score at 6 Month Follow-up Visit

University of California, Los Angeles (UCLA) activity score is questionnaire to assess intensity of patients' activity. The score ranges from 1 to 10 (1 point increment), higher score means higher activity level.

Time frame: 6 month postoperative

Population: 4 patients in BIOLOX delta head group and 12 patients in CoCr head group missed colleting UCLA Activity score at 6 month visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadUCLA Activity Score at 6 Month Follow-up Visit5.19 score on a scaleStandard Deviation 1.42
CoCr HeadUCLA Activity Score at 6 Month Follow-up Visit4.75 score on a scaleStandard Deviation 1.28
Secondary

WOMAC Osteoarthritis Index at 1 Year Follow-up Visit

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

Time frame: 1 year postoperative

Population: 6 patients in BIOLOX delta head group and 13 patients in CoCr head group missed colleting WOMAC questionnaire at 1 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadWOMAC Osteoarthritis Index at 1 Year Follow-up Visit9.86 score on a scaleStandard Deviation 13.52
CoCr HeadWOMAC Osteoarthritis Index at 1 Year Follow-up Visit9.57 score on a scaleStandard Deviation 9.23
Secondary

WOMAC Osteoarthritis Index at 2 Year Follow-up Visit

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

Time frame: 2 year postoperative

Population: 9 patients in BIOLOX delta head group and 16 patients in CoCr head group missed colleting WOMAC questionnaire at 2 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadWOMAC Osteoarthritis Index at 2 Year Follow-up Visit7.85 score on a scaleStandard Deviation 8.88
CoCr HeadWOMAC Osteoarthritis Index at 2 Year Follow-up Visit7.80 score on a scaleStandard Deviation 10.32
Secondary

WOMAC Osteoarthritis Index at 3 Year Follow-up Visit

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

Time frame: 3 year postoperative

Population: 14 patients in BIOLOX delta head group and 17 patients in CoCr head group missed colleting WOMAC questionnaire at 3 year visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadWOMAC Osteoarthritis Index at 3 Year Follow-up Visit8.29 score on a scaleStandard Deviation 9.31
CoCr HeadWOMAC Osteoarthritis Index at 3 Year Follow-up Visit6.84 score on a scaleStandard Deviation 8
Secondary

WOMAC Osteoarthritis Index at 6 Month Follow-up Visit

The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is used in evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items. The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a The total WOMAC score ranged from 0 to 96. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

Time frame: 6 month postoperative

Population: 6 patients in BIOLOX delta head group and 11 patients in CoCr head group missed colleting WOMAC questionnaire at 6 month visit.

ArmMeasureValue (MEAN)Dispersion
BIOLOX Delta HeadWOMAC Osteoarthritis Index at 6 Month Follow-up Visit9.27 score on a scaleStandard Deviation 9.75
CoCr HeadWOMAC Osteoarthritis Index at 6 Month Follow-up Visit10.43 score on a scaleStandard Deviation 9.62

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026